Disclosures for "The Uptake, Intracellular Trafficking and Recycling of FcRn-blocking Therapeutics in Human Endothelial Cells in Vitro"
-
Dr. Wallace has received personal compensation for serving as an employee of UCB. Dr. Wallace has or had stock in UCB.
-
Miss Sirina has nothing to disclose.
-
Dr. D'Hooghe has received personal compensation for serving as an employee of UCB. An immediate family member of Dr. D'Hooghe has received personal compensation for serving as an employee of UCB. An immediate family member of Dr. D'Hooghe has received personal compensation for serving as an employee of Relation Therapeutics. Dr. D'Hooghe has or had stock in UCB. An immediate family member of Dr. D'Hooghe has or had stock in UCB.
-
Laura A. Singhvi-Hanns has received personal compensation for serving as an employee of UCB.
-
Dr. Cole has nothing to disclose.
-
Dr. Lledo has received personal compensation for serving as an employee of UCB. Dr. Lledo has or had stock in UCB.
-
Dr. Ribera Armengol has received personal compensation for serving as an employee of UCB.
-
Anthony Shock has received personal compensation for serving as an employee of UCB Pharma.
-
Dr. Holliday has received personal compensation for serving as an employee of Excellerate Bioscience. Dr. Holliday has or had stock in Excellerate Bioscience.
-
Dr. Stoddart has nothing to disclose.